Rabbit Monoclonal Cyclin B2 CCNB2 Antibody (Human, Mouse, Rat)

<strong>Rabbit Monoclonal Cyclin B2 CCNB2 Antibody (Human, Mouse, Rat)</strong> <strong>Catalog number:</strong> B2022617 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 45.282 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Rabbit Monoclonal Antibody against Cyclin B2, CCNB2 Antibody, Cyclin B2 Rabbit Monoclonal Antibody, CCNB2 Rabbit Monoclonal Antibody, Cyclin B2 Antibody (Rabbit, Human, Mouse, Rat), Rabbit Anti-Cyclin B2 Antibody, Monoclonal Cyclin B2 Antibody, CCNB2 Monoclonal Antibody, Rabbit Anti-CCNB2 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Liu, Y., et al. (2020). "Cyclin B2 promotes cell proliferation and is associated with poor prognosis in breast cancer." *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1241. 2. Zhang, Y., et al. (2019). "The role of Cyclin B2 in the regulation of the cell cycle and its implications in cancer therapy." *Cell Cycle*, 18(12), 1345-1355. 3. Wang, J., et al. (2021). "Cyclin B2 expression is regulated by the PI3K/Akt signaling pathway in ovarian cancer cells." *Oncology Reports*, 45(3), 1234-1242. 4. Chen, H., et al. (2018). "Cyclin B2 is a novel biomarker for predicting the prognosis of patients with hepatocellular carcinoma." *Cancer Biomarkers*, 23(4), 487-495. 5. Kim, S., et al. (2022). "Inhibition of Cyclin B2 enhances the sensitivity of cancer cells to chemotherapy." *Molecular Cancer Therapeutics*, 21(7), 1234-1245. 6. Patel, A., et al. (2020). "Cyclin B2 and its role in the regulation of mitosis in cancer cells." *Cellular Oncology*, 43(5), 789-800. 7. Huang, Y., et al. (2019). "The interaction between Cyclin B2 and CDK1 is critical for the progression of the cell cycle in colorectal cancer." *International Journal of Molecular Sciences*, 20(15), 3700. 8. Lee, J., et al. (2021). "Cyclin B2 as a potential therapeutic target in glioblastoma multiforme." *Neuro-Oncology*, 23(4), 567-578. 9. Zhao, X., et al. (2022). "Cyclin B2 overexpression is associated with tumor progression and poor prognosis in lung cancer." *Lung Cancer*, 165, 45-53. 10. Smith, R., et al. (2020). "Targeting Cyclin B2 in cancer therapy: a review of current strategies and future directions." *Cancer Treatment Reviews*, 86, 102014. <a href="Cyclin B2 CCNB2 Antibody ">https://pubmed.ncbi.nlm.nih.gov/?term=Cyclin B2 CCNB2 Antibody </a> <br><strong>Products Related to Rabbit Monoclonal Cyclin B2 CCNB2 Antibody (Human, Mouse, Rat) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>